Akèy › Kansè (tout kalite) › Alabama › Huntsville
Etid klinik pou Kansè (tout kalite) nan Huntsville, AL
3 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Huntsville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Clearview Cancer Institute, Huntsville
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Ap rekriteFaz 2
- Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621, Huntsville
Collection and Distribution of Biospecimens for Novel Research Uses
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- iSpecimen, Huntsville
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
Lòt etid nan Huntsville
- Maladi kadyovaskilè8 etid
- Obèsite7 etid
- Maladi atè koronè6 etid
- Ensifizyans kadyak6 etid
- Twoub depresif majè6 etid
- Dyabèt Tip 26 etid
- Depresyon6 etid
- Ateroskleroz5 etid
- Sipwa5 etid
- Stenoz valv aòt4 etid
- Maladi ren kwonik4 etid
- Atak kè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.